Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00325585 · ClinicalTrials.gov registry record · Phase 2
HIV Prevention Intervention for Couples
A Phase 2 study of Acquired Immunodeficiency Syndrome, sponsored by National Development and Research Institutes.
- Completed
- Registry status
- Phase 2
- Development phase
- 780
- Enrollment target
- 1
- Study location
NCT00325585: Completed Phase 2 study of Acquired Immunodeficiency Syndrome, sponsored by National Development and Research Institutes.
NCT00325585 is a Phase 2 study of Acquired Immunodeficiency Syndrome that has completed, run by National Development and Research Institutes. The registered enrollment target is 780 participants, above the 171-participant average among 17 other Acquired Immunodeficiency Syndrome trials with a reported enrollment target (356% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00325585, a Phase 2 study of Acquired Immunodeficiency Syndrome, has completed, sponsored by National Development and Research Institutes.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 780 participants
- Enrollment target
- 1
- Study location
Study Summary
Recent studies have shown that many drug-using minority women are vulnerable to HIV infection from their husbands or other intimate male partners. The goal of this study is to develop and evaluate two new HIV counseling and testing programs designed for drug-using women at risk for HIV from a primary male partner. It is predicted that HIV counseling and testing programs administered to couples rather than to women only, and programs that focus on intimate relationships in the context of HIV risk, will result in a reduction of risky sexual and drug-related behavior among drug-using women and their primary male partners. This four-year study employs a randomized clinical trial (RCT) design to test the effectiveness of two new HIV counseling and testing programs for women drug-users in Harlem and the South Bronx in New York City.
Conditions Studied
Interventions
- BEHAVIORAL Couples HIV counseling and testing
- BEHAVIORAL Women's relationship-focused HIV counseling and testing
Study Locations (1)
New York
- NDRI South Bronx Field Office - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
What the finished NCT00325585 record still lists
NCT00325585 is an interventional study that assigns participants to a tested intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, above the 171-participant average among 17 other Acquired Immunodeficiency Syndrome trials with a reported enrollment target (356% higher).
The record links to 1 condition, with Acquired Immunodeficiency Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Couples HIV counseling and testing is the first listed.
NCT00325585 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00325585 about?
NCT00325585 is a clinical study titled "HIV Prevention Intervention for Couples". Recent studies have shown that many drug-using minority women are vulnerable to HIV infection from their husbands or other intimate male partners. The goal of this study is to develop and evaluate two new HIV counseling and testing programs designed for drug-using women at risk for HIV from a primar...
What is the current status of trial NCT00325585?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 780 participants. The study started on 2005-04. Estimated completion is 2008-06.
What conditions does trial NCT00325585 study?
This clinical trial studies the following conditions: Acquired Immunodeficiency Syndrome.
What interventions are being tested in trial NCT00325585?
The interventions under investigation include: Couples HIV counseling and testing (BEHAVIORAL), Women's relationship-focused HIV counseling and testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00325585?
This trial is sponsored by National Development and Research Institutes, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00325585 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acquired Immunodeficiency Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00325585's enrollment target sits among peer trials
780 1st of 17 higher than 17 of 17 other Acquired Immunodeficiency Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acquired Immunodeficiency Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
RECRUITING · Phase 2
-
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
COMPLETED · Phase 2
-
Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults
ACTIVE NOT RECRUITING · Phase 1
-
Twins Study of Gene Therapy for HIV Infection
COMPLETED · Phase 1
-
Mesalamine to Reduce T Cell Activation in HIV Infection
COMPLETED · Phase 4
-
Managerial Database II
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- NCT05513872 · 780 participants · Phase 1
Overcoming Nicotine Dependence to Enable Quitting
- NCT06310031 · 780 participants · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia